When Recombinant Human CD155/PVR (Catalog # 2530-CD) is immobilized at2.5 µg/mL, Recombinant Human TIGIT Fc Chimera (Catalog # 7898-TGB) binds with an ED50 of 40-200 ng/mL.
Recombinant Human CD155/PVR His-tag Protein, CF Summary
Details of Functionality
Measured by its binding ability in a functional ELISA. When Recombinant Human CD155/PVR is coated at 2.5 μg/mL (100 μL/well), the concentration of Recombinant Human TIGIT Fc Chimera (Catalog # 7898-TGB) that produces 50% optimal binding response is 40-200 ng/mL.
Source
Mouse myeloma cell line, NS0-derived human CD155/PVR protein Gly27-Asn343, with a C-terminal 6-His tag
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Binding Activity
Theoretical MW
35.3 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
62-70 kDa, reducing conditions
Publications
Read Publication using 2530-CD/CF in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after opening.
Buffer
Supplied as a 0.2 μm filtered solution in PBS.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human CD155/PVR His-tag Protein, CF
CD155 antigen
CD155
HVED
NECL5
Necl-5
nectin-like 5
Nectin-like protein 5
poliovirus receptor
PVR
PVS
PVSFLJ25946
Tage4
Background
CD155, also known as PVR (poliovirus receptor), Necl-5 (nectin-like molecule-5) and, in rodents, TAGE4 (tumor-associated glycoprotein E4), is a 70 kDa type I transmembrane glycoprotein in the nectin-related family of adhesion proteins within the immunoglobulin superfamily (1, 2). CD155 binds other molecules including Vitronectin, Nectin-3, DNAM-1/CD226, CD96, and TIGIT but does not bind homotypically (3). Mature human CD155 consists of a 323 amino acid (aa) extracellular domain (ECD) with one N-terminal V-type and two C2-type Ig-like domains, a 24 aa transmembrane segment, and a 50 aa cytoplasmic tail. Within the ECD, human CD155 shares 45% aa sequence identity with mouse and rat CD155, and 52% with human Nectin-2. The V-type domain of CD155 mediates all binding, including to polio virus (1), and alternative splicing within this domain in humans can modulate ligand binding (4). Human CD155 can also be spliced to generate secreted isoforms (5). CD155 is up-regulated on endothelial cells by IFN-gamma and is highly expressed on immature thymocytes, lymph node dendritic cells, and tumor cells of epithelial and neuronal origin (1, 2, 6-9). It is preferentially expressed on Th17 cells compared to Th2 cells (10), and its activation promotes the development of Th1 responses (11). On migrating cells, CD155 is concentrated at the leading edge, where it binds basement membrane Vitronectin, recruits Nectin-3-expressing cells, and cooperates with PDGF and Integrin alpha v beta 3 to promote cell migration (1, 3, 12). Enhanced CD155 expression in tumor cells contributes to loss of contact inhibition and increased migration but also allows tumor cell recognition and killing by DNAM-1 or CD96 expressing NK cells (1, 7, 13). Binding of monocyte DNAM-1 to endothelial cell CD155 promotes transendothelial migration (8). The expression of CD155 on mouse CD8+ thymocytes prevents their premature exit from the thymus (14). Within intestinal Peyer's patches, follicular dendritic cell CD155 activates follicular helper T cells via DNAM-1 or CD96 binding (7-9, 15). CD155 also binds the inhibitory ligand TIGIT on NK and some mature T cells, antagonizing DNAM-1 effects (7, 15, 16).
Mandai, K. et al. (2015) Curr. Top. Dev. Biol. 112:197.
Mendelsohn, C.L. et al. (1989) Cell 56:855.
Sato, T. et al. (2004) Genes to Cells 9:791.
Meyer, D. et al. (2009) J. Biol. Chem. 284:2235.
Koike, S. et al. (1990) EMBO J. 9:3217.
Escalante, N.K. et al. (2011) Arterioscler. Thromb. Vasc. Biol. 31:1177.
Xu, Z. and B. Jin (2010) Cell. Mol. Immunol. 7:11.
Reymond, N. et al. (2004) J. Exp. Med. 199:1331.
Maier, M.K. et al. (2007) Eur. J. Immunol. 37 :2214.
Lozano, E. et al. (2013) J. Immunol. 191:3673.
Yamashita-Kanemaru, Y. et al. (2015) J. Immunol. 194:5644.
Mueller, S. and E. Wimmer (2003) J. Biol. Chem. 278:31251.
Chan, C.J. et al. (2010) J. Immunol. 184:902.
Qui, Q. et al. (2010) J. Immunol. 184:1681.
Seth, S. et al. (2009) Eur. J. Immunol. 39:3160.
Stanietsky, N. et al. (2009) Proc. Natl. Acad. Sci. USA 106:17858.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human CD155/PVR His-tag Protein, CF and receive a gift card or discount.